Omega Life Science

Company Overview

Snapshot

Founded in January 2011, Omega Life Science operates with 1–10 employees. The company has developed a proprietary inhaler platform, Alphazer, which produces aerosols for drug delivery.

Business overview

Omega Life Science specializes in developing medical devices for aerosol drug delivery, focusing on systemic, local, and CNS targeting. The company's core technology includes a proprietary inhaler platform, Alphazer, and tailor-made formulation technology. This platform generates submicron- to micron-sized droplets and submicron- to nano-sized dry particles of pharmaceutical compounds. Omega Life Science serves the healthcare and life sciences industries, particularly targeting pharmaceuticals, patients, and providers with its inhalation and drug delivery solutions.

Company Intelligence Q&A

What is Omega Life Science's primary focus?

Omega Life Science focuses on developing medical devices for aerosol drug delivery, utilizing a proprietary inhaler and formulation technology for systemic, local, and CNS targeting.

What is the Alphazer platform?

The Alphazer is Omega Life Science's proprietary inhaler platform designed to produce submicron- to micron-sized droplets and submicron- to nano-sized dry particles of pharmaceutical compounds for drug delivery.

What markets does Omega Life Science serve?

Omega Life Science serves the global market, targeting the healthcare and life sciences sectors, including pharmaceuticals, patients, and providers.

What types of products does Omega Life Science offer?

Omega Life Science offers products such as Aquaphazer and Alphazer, which are part of its aerosol drug delivery system.

What is the company's employee count?

Omega Life Science operates with 1–10 employees.